CAT Analyst Slashes Rating and 3 Movers Demanding Investor Attention
E.I. du Pont de Nemours & Company (NYSE:DD) shares closed at a 52-week low of $43.34, some 19.7 percent below the 52-week high of $53.80. The company has a current market cap of $40.32 billion and involves itself in science and tech through a number of disciplines which include specialty chemicals, high-performance materials, pharmaceuticals and biotechnology. Shares were traded with a price-to-equity ratio of 11.17 and P/S ratio of 1.04 with a dividend yield of 3.97 percent. The firm has posted an annual average earnings growth of 5.1 percent over the past 10 years.
Caterpillar (NYSE:CAT) had its rating and price target lowered Monday at J.P. Morgan as mining companies endeavor to place a ceiling on capital expenditures. The analysts also think that the energy sector could see added regulatory hurdles subsequent to the re-election of President Barack Obama.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now!
International Business Machines Corporation (NYSE:IBM) reports new software and service improvements to its Mobile Enterprise suite. A combination of first-time features, consulting programs, and repackaged mixtures of existing tech should run the range of mobility needs.
Procter & Gamble Co. (NYSE:PG) and the Israeli drug manufacturer Teva Pharmaceuticals (NYSE:TEVA) have been approved by regulators in Europe to market over-the-counter medicines. Accordingly, the firms anticipate that PGT Healthcare should begin with$1.3 billion in yearly sales with P&G’s brands like Metamucil and Pepto-Bismol, Vicks, and Teva’s lines of over-the-counter cold and other medicines and its pharmacy distribution network. It is expected that the partnership could increase sales to approximately $4 billion annually by the end of the decade.